CMS Enters the Octagon, Names 10 Drugs for Price Negotiation

Health Affairs' Rob Lott and Chris Fleming discuss Biden administration's announcement regarding the first 10 drugs selected for Medicare price negotiation.Listen to the Research and Justice For All trailer.Related Link:Biden-Harris Administration Announces First Ten Drugs Selected for Medicare Price NegotiationA Deep Dive Into Takings Clause Challenges to the Medicare Drug Price Negotiation Program (Health Affairs Forefront)Medicare Drug Price Negotiations: A Principles-Based Guide for CMS (Health Affairs Forefront)